Using AI to detect pancreatic cancer early
Official title: Multimodal AI Fusion Model for Early Detection for Pancreatic Cancer
Funded at Mayo Clinic Arizona · NIH-10857089 · Data updated 2026-11-12
This study is testing a new tool that uses CT scans and other health information to help find pancreatic cancer early, even in people who don’t have any symptoms yet, and it aims to make sure it works well for everyone, no matter their background.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Mayo Clinic Arizona NIH-funded |
| Lab location | 1 site (Scottsdale, United States) |
| Project start | September 16, 2024 |
| Project end | August 31, 2029 |
| Funding year | 2024 |
| Award (this year) | $599,757 |
| NIH project number | 1R01CA289249-01 |
| Project ID | NIH-10857089 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are asymptomatic individuals at risk for pancreatic cancer, particularly those with factors like age, obesity, or diabetes.
✕Less likely to help
Patients who are already diagnosed with pancreatic cancer or those with advanced disease may not benefit from this research.
What this research studies
This research focuses on developing a new model called PRECISE that combines imaging data from CT scans with other clinical information to improve early detection of pancreatic cancer. By utilizing advanced deep learning techniques, the project aims to identify pre-cancerous changes in patients who currently show no symptoms. The model will also ensure that it works fairly across different demographic groups, addressing potential biases in detection. The research will validate its findings using data from reputable institutions like Mayo Clinic and Cornell University.
Why it matters
Potential benefit: If successful, this research could lead to earlier diagnosis of pancreatic cancer, significantly improving treatment outcomes and survival rates.
How similar studies have gone: Previous research has shown promise in using imaging biomarkers for cancer detection, suggesting that this approach could be effective.
Where this research is happening
-
Mayo Clinic Arizona
Scottsdale, United States Active
Researchers
- Principal investigator: Banerjee, Imon — Mayo Clinic Arizona
- Study coordinator: Banerjee, Imon
Related research
Other NIH-funded projects on the same topics.
-
Microbial Dysbiosis and Its Role in Pancreatic Cancer
A doctor-researcher team at Northwestern University is studying how gut bacteria influence pancreatic cancer and its response to immunotherapy to find new ways to help patients.
-
Targeting aberrant enhancer landscapes in pancreatic cancer
A patient-facing look at a project that aims to understand how pancreatic cancer changes its cell identity and what that means for treatment.
-
Exosome-based microRNA biomarkers for early, non-invasive detection of pancreatic cancer
A study to develop a blood test that uses tiny RNA signals in exosomes to detect pancreatic cancer early, aiming to help people at risk or with early disease.
-
Exosome-based microRNA biomarkers for early detection of pancreatic cancer
A patient-friendly look at a study using tiny blood-based RNA markers inside exosomes to catch pancreatic cancer early without invasive procedures.
-
Programmable implanted living materials to fight pancreatic cancer
A patient-facing program will explore a safe, implantable living material that delivers sequential immunotherapies directly to pancreatic tumors to help fight cancer.
-
Targeting how platelets and pancreatic cancer talk to each other
A study exploring whether blocking the interaction between platelets and pancreatic cancer cells could slow cancer growth and spread and help identify new biomarkers.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.